Breaking News

Sterling Pharma Aquires CiVentiChem in the US

Enhance chemistry development capabilities to support pre-clinical and early phase clinical supply

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

UK-based contract development and manufacturing organization (CDMO), Sterling Pharma Solutions, has acquired CiVentiChem’s U.S. facility located in Cary, NC.   The new facility, located close to the Research Triangle Park, will allow Sterling to offer a local presence to its U.S. clients and enhance its chemistry development capabilities to support pre-clinical and early phase clinical supply.    The acquisition follows Sterling’s record growth, with the company more than doubling its sales sinc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters